BridgeBio has demonstrably advanced the development of a innovative treatment for amyloid heart disease, employing the investigational drug. Early clinical data reveals significant outcomes for those suffering from the https://bridgebio182351.frewwebs.com/40766937/company-advances-cardiac-amyloidosis-treatment-with-the-drug